Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Venous Thrombosis 1Thrombosis 1Thromboembolism 1Testicular Neoplasms 1Sezary Syndrome 1Sarcoma 1Resected Liver Metastases From Colorectal Cancer 1Recurrence 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Mycosis Fungoides 1Metabolic Diseases 1Melanoma 1Malignant Female Reproductive System Neoplasm 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

apixaban 5Enoxaparin 4Dalteparin 4Warfarin 2Rivaroxaban 2Injections 2Heparin, Low-Molecular-Weight 2Aspirin 2salicylhydroxamic acid 1palbociclib 1fluorescein isothiocyanate-keyhole limpet hemocyanin 1enoxaparin sodium 1edoxaban 1bemiparin 1X-Rays 1Tinzaparin 1Technetium Tc 99m Sulfur Colloid 1Simvastatin 1Saline Solution 1Radiotherapy, Conformal 1Physical Therapy Modalities 1Photons 1Phlebotomy 1Paclitaxel 1Observation 1Musculoskeletal Manipulations 1Hydroxyurea 1Heparin 1Fondaparinux 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thrombosis × Heparin × Clear all
NCT01820962 2013-03-29

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Maastricht University Medical Center

Phase 3 Terminated
212 enrolled
Other hematologic neoplasm

Thrombosis, Bacteremia, Hematologic Neoplasms, Catheter-Related Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡